Um die volle Funktionalität der Webseite nutzen zu können, müssen Sie JavaScript in ihrem Browser aktivieren.

DAX23.715,08+1,25 %

Gold3.323,35-1,35 %

Öl (Brent)66,75-5,96 %

Dow Jones43.102,51+1,23 %

US Tech 10022.192,17+1,55 %

EUR/USD1,16095+0,27 %

Top 15 der gesamten Suchanfragen der letzten 7 Tage

Login

Iovance Biotherapeutics Aktie

Aktie

ISIN: US4622601007 WKN: A2DT49 Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

1,6235

EUR

+1,47 %

+0,0235 EUR

Letzter Kurs 22:49:21 Lang & Schwarz

Iovance Biotherapeutics Aktie kaufen

Geldkurs

22:49:21

1,6180

EUR

6.369 STK

Briefkurs

22:49:21

1,6290

EUR

6.369 STK

BEI SMARTBROKER+ HANDELN

Handeln über unsere
Partner-Broker

Brokerize

Neueste Nachrichten

Iovance Biotherapeutics, Inc. Investors are Notified to Contact BFA Law by July 14 Deadline to Potentially Recover Losses in Securities Fraud Class Action 21:22 Uhr · newsfile · Iovance Biotherapeutics
Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure - Hagens Berman 19:36 Uhr · newsfile · Iovance Biotherapeutics
IOVANCE FRAUD: BFA Law Reminds Iovance Biotherapeutics, Inc. (IOVA) Investors with Losses to Contact the Firm Prior to the July 14 Class Action Deadline 23.06.25 · newsfile · Iovance Biotherapeutics
Scott+Scott Attorneys at Law LLP Reminds Investors Of The Class Action That Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA) 23.06.25 · newsfile · Iovance Biotherapeutics
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics 23.06.25 · newsfile · Iovance Biotherapeutics
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit 22.06.25 · newsfile · Iovance Biotherapeutics
ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA 22.06.25 · newsfile · Iovance Biotherapeutics
IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP 22.06.25 · newsfile · Iovance Biotherapeutics
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics 21.06.25 · newsfile · Iovance Biotherapeutics
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA 21.06.25 · newsfile · Iovance Biotherapeutics
IOVA FRAUD NOTICE: Iovance Biotherapeutics, Inc. Shareholders that Lost Money are Reminded to Contact BFA Law by the July 14 Securities Fraud Class Action Deadline 21.06.25 · newsfile · Iovance Biotherapeutics
Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA) 20.06.25 · newsfile · Iovance Biotherapeutics

1
2
3
4
5
…
9

Meistgelesen

24 Stunden
7 Tage
30 Tage
12 Monate

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure - Hagens Berman 104 Leser
Iovance Biotherapeutics, Inc. Investors are Notified to Contact BFA Law by July 14 Deadline to ... 100 Leser

IOVA COURT ALERT: Investors of Iovance Biotherapeutics, Inc. that Lost Money are Notified to ... 148 Leser
IOVA REMINDER: Iovance Biotherapeutics, Inc. Investors are Reminded to Contact BFA Law by July 14 ... 144 Leser
Scott+Scott Attorneys at Law LLP Reminds Investors Of The Class Action That Has Been Filed Against ... 140 Leser
IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit ... 136 Leser
IOVA FRAUD NOTICE: Iovance Biotherapeutics, Inc. Shareholders that Lost Money are Reminded to ... 132 Leser
IOVANCE FRAUD: BFA Law Reminds Iovance Biotherapeutics, Inc. (IOVA) Investors with Losses to ... 132 Leser
Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Class Action Was Filed Against ... 132 Leser
Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure- Hagens Berman 128 Leser
ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel ... 128 Leser
ROSEN, A TOP RANKED LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel ... 124 Leser

Scott+Scott Attorneys at Law LLP Alerts Investors of the Securities Class Action Against Iovance ... 284 Leser
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure ... 260 Leser
IOVA SHAREHOLDER NOTICE: BFA Law Alerts Iovance Biotherapeutics, Inc. Investors to Contact the Firm ... 168 Leser
Scott+Scott Attorneys at Law LLP Reminds Investors of the Class Action Against Iovance ... 160 Leser
Scott+Scott Attorneys at Law LLP Continues to Remind Investors of The Ongoing Securities Class ... 160 Leser
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... 160 Leser
IOVA SECURITIES UPDATE: Iovance Biotherapeutics, Inc. Investors with Losses are Reminded of the ... 156 Leser
IOVA INVESTOR REMINDER: BFA Law Reminds Iovance Biotherapeutics, Inc. Investors to Contact the Firm ... 152 Leser
Iovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit- ... 152 Leser
Scott+Scott Attorneys at Law LLP Reminds Investors of The Securities Action That Has Been Filed ... 148 Leser

Fokus Aktien mit extremen Handelsvolumen am Freitag, den 09.05.2025 592 Leser
Biotechnologie: Weltweiter Markt für Zelltherapie soll bis 2034 jährlich um 20% wachsen 404 Leser
Securities Fraud Investigation Into Iovance Biotherapeutics, Inc. (IOVA) Announced – Investors ... 404 Leser
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. ... 304 Leser
Scott+Scott Attorneys at Law LLP Alerts Investors of the Securities Class Action Against Iovance ... 284 Leser
Securities Fraud Investigation Into Iovance Biotherapeutics, Inc. (IOVA) Announced – Investors ... 280 Leser
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure ... 260 Leser
IOVA CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Iovance Biotherapeutics, ... 184 Leser
Iovance Biotherapeutics’ (IOVA) Annual Maintenance: Assurances Collide with Adverse Disclosure as Shares Plunge 44% – Hagens Berman 172 Leser
IOVA SHAREHOLDER NOTICE: BFA Law Alerts Iovance Biotherapeutics, Inc. Investors to Contact the Firm ... 168 Leser